Status:
UNKNOWN
Transcranial Pulse Stimulation Open-label Self-controlled Trial For Mild Neurocognitive Disorder
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Storz Medical AG
Conditions:
Mild Neurocognitive Disorder
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Background: A significant proportion of older adults suffered from age-related diseases particularly dementia, also known as major neurocognitive disorder (NCD), which is becoming a worldwide health ...
Detailed Description
Background Age-related diseases, particularly dementia, now known as major neurocognitive disorder (NCD), are a great health burden in Hong Kong and worldwide. Interventions that aim to ameliorate cog...
Eligibility Criteria
Inclusion
- 1\. 60 years of age or above
- 2\. Chinese ethnicity
- 3\. Mild neurocognitive disorder (NCD) meeting the 5th Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria
- 4\. At least 3 months of stable anti-dementia therapy prior to enrolment (unchanged medication, if receiving)
- 5\. Written informed consent
Exclusion
- 1\. A HK-MoCA score below the second percentile according to the subject's age and education level
- 2\. Alcohol or substance dependence
- 3\. Concomitant unstable major medical conditions or major neurological conditions such as brain tumour, brain aneurysm
- 4\. Haemophilia or other blood clotting disorders or thrombosis
- 5\. Significant communicative impairments
- 6\. Participants with any metal implant in brain or treated area of the head
Key Trial Info
Start Date :
January 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05331560
Start Date
January 20 2020
End Date
July 30 2024
Last Update
April 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hong Kong Jockey Club Building for Interdisciplinary Research
Hong Kong, Hong Kong